COMMERCIALIZING WORLD-CLASS CANCER INNOVATION

Seeding and scaling Ontario’s premiere entrepreneurial ventures for patients and the economy.

ONTARIO RESEARCH Leveraging breakthrough innovation and community network COMMERCIALIZATION VENTURE Investing seed capital, creating & scaling start-ups, securing strategic partners PATIENT & ECONOMIC IMPACT Driving clinical trials, job creation, talent development, sustainable biotech in Ontario ONTARIO RESEARCH Leveraging breakthrough innovation and community network COMMERCIALIZATION VENTURE Investing seed capital, creating & scaling start-ups, securing strategic partners PATIENT & ECONOMIC IMPACT Driving clinical trials, job creation, talent development, sustainable biotech in Ontario

OUR IMPACT

Increasing the value of Ontario’s best oncology innovations and attracting investment from the private sector

invested

additional financing attracted

Ontario start-ups created

first-in-human studies

PORTFOLIO

Our investments are at the forefront of Ontario’s biotech ecosystem.

FIND OUT MORE

FUNDS

Our investments bridge the life sciences seed funding gap.

FIND OUT MORE

KEY SUCCESSES

Our investments have resulted in significant partnerships, clinical trials, job creation and leveraged financing for the province.

RECENT NEWS

Keep up to date on our investments and business developments in recent news stories and summaries.

  • FACIT and OBIO® announce inaugural WeSEED cohort of women-led start-ups in joint seed capital and commercialization program

    March 6, 2025 – The Women’s Synergistic Entrepreneurship and Economic Development (WeSEED) program leverages the combined, complementary capital, expertise and resources of OBIO® and FACIT. The resulting synergies provide a continuum of seamless support and lower barriers faced by women STEM leaders in accessing business training, advisory resources, networks and venture funding. Read More from…

    Read More

  • RSVP for Falcons’ Fortunes Pitch Finals on March 20, 2025

    February 4, 2025 – The annual Falcons’ Fortunes event, hosted by FACIT, features six Ontario entrepreneurs vying for the $100,000 award in the province’s only pitch competition specifically promoting cancer breakthroughs. Now in its 12th year, Falcons’ Fortunes is FACIT’s premier event to celebrate and grow the entrepreneurial spirit within the cancer research community. FACIT is…

    Read More

  • Idea to Investment Podcast: How FACIT’s support propels early cancer innovations

    January 17, 2025 – FACIT’s David Koehler, Director of Fund Operations, appeared on TechAlliance’s Idea to Investment podcast along with Saumik Biswas, President, CEO and Founder of Tenomix Inc. based in London, Ontario. Tenomix’s advancements exemplifies how FACIT’s continuum of commercialization programs can strategically capitalize on homegrown talent and innovations to spur promising start-ups to…

    Read More

We were established by the Ontario Institute for Cancer Research (OICR) to support commercialization, technology transfer, and development activities. OICR conducts and enables world-class cancer research, filling a critical role as a pan-provincial connector of oncology researchers, resources and cancer innovation development. Together with OICR, we drive a shared vision to attract more R&D investment in Ontario and help the best oncology innovations reach the market and save lives. 

FACIT is funded in part by the Government of Ontario through OICR